Circular Genomics Partners with Renowned Institutions to Enhance Alzheimer's Blood Test Technology Circular Genomics has secured exclusive IP licenses from top research institutions to boost their innovative circRNA blood test for Alzheimer's disease, aimed at improving early diagnosis.

Circular Genomics Partners with Renowned Institutions to Enhance Alzheimer's Blood Test Technology #USA #San_Diego #Alzheimer's #Circular_Genomics #circRNA

Circular Genomics Expands Advisory Board with Leading Alzheimer's Researchers to Enhance Neurology Advances Circular Genomics announces the appointment of distinguished experts Michael Weiner and Timothy Hohman to its Scientific Advisory Board. This move aims to enhance advancements in Alzheimer's disease diagnostics.

Circular Genomics Expands Advisory Board with Leading Alzheimer's Researchers to Enhance Neurology Advances #USA #San_Diego #Circular_Genomics #Alzheimer's_Research #Neurology_Experts

Circular Genomics Secures $15 Million to Enhance Alzheimer's Detection with Circular RNA Technology Circular Genomics has successfully raised $15 million to support the development of its innovative circular RNA-based platform for early Alzheimer's diagnostics.

Circular Genomics Secures $15 Million to Enhance Alzheimer's Detection with Circular RNA Technology #United_States #San_Diego #Alzheimer's_Disease #Circular_Genomics #circRNA_Biomarkers

Circular Genomics to Present Groundbreaking Blood Biomarkers for Alzheimer's Disease at CTAD 2025 Discover how Circular Genomics' innovative circular RNA biomarker platform is revolutionizing early detection of Alzheimer's Disease at CTAD 2025.

Circular Genomics to Present Groundbreaking Blood Biomarkers for Alzheimer's Disease at CTAD 2025 #United_States #San_Diego #Alzheimer's_Disease #Circular_Genomics #circRNA

Circular Genomics Secures $250K from ADDF to Enhance Alzheimer's Detection with CircRNA Biomarkers Circular Genomics has been awarded a $250K investment from the Alzheimer's Drug Discovery Foundation to advance blood-based circRNA biomarker tests for early Alzheimer's detection.

Circular Genomics Secures $250K from ADDF to Enhance Alzheimer's Detection with CircRNA Biomarkers #United_States #San_Diego #Alzheimer's_Disease #Circular_Genomics #circRNA_Biomarkers

Circular Genomics Strengthens Its Leadership with New Commercial Advisory Board for Neurology Innovations Circular Genomics has formed a new Commercial Advisory Board to bolster its precision medicine initiatives in neurology and psychiatry. This strategic move aims to enhance market access and patient care.

Circular Genomics Strengthens Its Leadership with New Commercial Advisory Board for Neurology Innovations #USA #San_Diego #Advisory_Board #Circular_Genomics #circRNA

Circular Genomics Enhances Scientific Advisory Board with Alzheimer's Specialist Appointment Circular Genomics has appointed Phyllis Barkman Ferrell, a prominent Alzheimer's expert, to its Scientific Advisory Board to enhance its approach for psychiatric and neurological disorders.

Circular Genomics Enhances Scientific Advisory Board with Alzheimer's Specialist Appointment #United_States #San_Diego #Alzheimer's_Disease #Circular_Genomics #Dr._Ferrell

Circular Genomics Partners with Lilly Gateway Labs to Enhance Alzheimer's Diagnosis Using Circular RNA Technologies Circular Genomics is now collaborating with Lilly Gateway Labs in San Diego to advance the use of circular RNA technologies for enhancing Alzheimer's disease diagnosis and prognosis.

Circular Genomics Partners with Lilly Gateway Labs to Enhance Alzheimer's Diagnosis Using Circular RNA Technologies #United_States #San_Diego #Alzheimer's_Disease #Circular_Genomics #Lilly_Gateway_Labs